TalkMed Group

Results

TalkMed's 3Q earnings fall 17% to $7.1 mil

SINGAPORE (Nov 7): Healthcare company TalkMed Group posts a 17.2% decline in earnings to $7.1 million in the 3Q ended September, from $8.6 million a year ago.

Sector Focus

These 2 new entrants hold the biggest weights on the FTSE ST Catalist Index

SINGAPORE (Sept 27): New entrants UnUsUaL and Kimly now maintain the two highest weights on the FTSE ST Catalist Index, at 6% and 5% respectively.

In print this week

Healthcare stocks: To buy or not to buy?

SINGAPORE (Aug 25): Dr Ang Peng Tiam renowned oncologist and CEO of TalkMed Group specialises in treatment and palliative care for people suffering from cancer.

Broker's Calls

CEO’s suspension a short term roadblock in TalkMed’s long term future, says RHB

SINGAPORE (June 29): RHB is maintaining its “buy” call on TalkMed Group with a lower target price of 73 cents from $1.03 previously following Wednesday’s news of the eight-month suspension of its CEO, Dr Ang Peng Tiam, starting from July 25.  
  •  
×